Evidence map›Paper›PMID 34626077›Full record

ArticleThe clinical respiratory journal2022

Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.

Nilüfer Aylin Acet-Öztürk, Asli G Dilektasli, Özge Aydın-Güçlü, Ezgi Demirdöğen, Funda Coşkun, Ahmet Ursavaş, Mehmet Karadağ, Esra Uzaslan

Open access · hybridAbstract read
In one paragraph

Article in The clinical respiratory journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nilüfer Aylin Acet-ÖztürkFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.ORCID https://orcid.org/0000-0002-6375-1472
Asli G DilektasliFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.
Özge Aydın-GüçlüFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.ORCID https://orcid.org/0000-0003-1005-3205
Ezgi DemirdöğenFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.ORCID https://orcid.org/0000-0002-7400-9089
Funda CoşkunFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.
Ahmet UrsavaşFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.
Mehmet KaradağFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.
Esra UzaslanFaculty of Medicine, Department of Pulmonology, Uludağ University, Bursa, Turkey.
Bursa Uludağ Üni̇versi̇tesi̇ · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEosinophilic airway inflammation is a recognized inflammatory pattern in subgroups of patients with chronic obstructive pulmonary disease (COPD). However, there are still conflicting results between various studies concerning the effect of eosinophils in COPD patients. Our aim with this study was to evaluate eosinophilic inflammation and its relation to the clinical characteristics in a group of COPD patients.

methodsStable COPD patients with FEV

resultsWe included 90 male COPD patients, with a mean age of 63.3 ± 9.2. Mean FEV

conclusionOur study supports the growing evidence for a potential role of eosinophilic inflammation phenotype in COPD with distinctive clinical characteristics. Eosinophilic inflammation is inversely associated with dyspnea severity measured by mMRC and LTOT use independently from age, total number of exacerbations, St. George Respiratory Questionnaire (SGRQ) total score and FEV

Indexed as

Pulmonary Disease, Chronic ObstructiveQuality of LifeAgedDisease ProgressionEosinophilsHumansLungMaleMiddle AgedOxygenOxygenCOPDeosinophilinflammationsupplemental oxygen

Identifiers

PMID34626077
PMCPMC9060034
OpenAlexW3204154647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.